Literature DB >> 12927857

Synthesis and structure-activity relationships of a series of pyrrole cannabinoid receptor agonists.

Giorgio Tarzia1, Andrea Duranti, Andrea Tontini, Gilberto Spadoni, Marco Mor, Silvia Rivara, Pier Vincenzo Plazzi, Satish Kathuria, Daniele Piomelli.   

Abstract

We designed and synthesized a series of pyrrole derivatives with the aim of investigating the structure-activity relationship (SAR) for the binding of non-classical agonists to CB(1) and CB(2) cannabinoid receptors. Superposition of two pyrrole-containing cannabinoid agonists, JWH-007 and JWH-161, allowed us to identify positions 1, 3 and 4 of the pyrrole nucleus as amenable to additional investigation. We prepared the 1-alkyl-2,5-dimethyl-3,4-substituted pyrroles 10a-e, 11a-d, 17, 21, 25 and the tetrahydroindole 15, and evaluated their ability to bind to and activate cannabinoid receptors. Noteworthy in this set of compounds are the 4-bromopyrrole 11a, which has an affinity for CB(1) and CB(2) receptors comparable to that of well-characterized heterocyclic cannabimimetics such as Win-55,212-2; the amide 25, which, although possessing a moderate affinity for cannabinoid receptors, demonstrates that the 3-naphthoyl group, commonly present in indole and pyrrole cannabimimetics, can be substituted by alternative moieties; and compounds 10d, 11d, showing CB(1) partial agonist properties.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12927857     DOI: 10.1016/s0968-0896(03)00413-9

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.

Authors:  D Fegley; S Kathuria; R Mercier; C Li; A Goutopoulos; A Makriyannis; D Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-11       Impact factor: 11.205

Review 2.  What we know and do not know about the cannabinoid receptor 2 (CB2).

Authors:  Anna Maria Malfitano; Sreemanti Basu; Katarzyna Maresz; Maurizio Bifulco; Bonnie N Dittel
Journal:  Semin Immunol       Date:  2014-05-28       Impact factor: 11.130

3.  Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice.

Authors:  Jesse LoVerme; Andrea Duranti; Andrea Tontini; Gilberto Spadoni; Marco Mor; Silvia Rivara; Nephi Stella; Cong Xu; Giorgio Tarzia; Daniele Piomelli
Journal:  Bioorg Med Chem Lett       Date:  2008-12-24       Impact factor: 2.823

Review 4.  Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

Authors:  Marisol S Castaneto; David A Gorelick; Nathalie A Desrosiers; Rebecca L Hartman; Sandrine Pirard; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2014-08-18       Impact factor: 4.492

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.